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Separate Pathways for Antigen Presentation
by CD1 Molecules
Given the variety of pathways for entry of pathogens
into host cells and for intracellular delivery of their prod-
ucts, each of these antigen-presenting molecules must
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compartments that may contain relevant antigens. In theBrigham and Women's Hospital
Harvard Medical School endogenous pathway of protein antigen presentation,
cytosolic peptides, such as those derived from viral pro-Boston, Massachusetts 02115
²The Netherlands Cancer Institute teins synthesized in virus-infected cells, are transported
into the endoplasmic reticulum (ER) through an ER mem-Plesmanlaan 121-H4
1066 CX Amsterdam brane±associated peptide transporter encoded by the
TAP genes. The peptides are then sampled in the ERThe Netherlands
³Department of Environmental Health by MHC class I molecules and presented to CD81 cyto-
toxic T cells capable of eliminating the virus-infectedHarvard School of Public Health
Boston, Massachusetts 02115 cells (Heemels and Ploegh, 1995). In contrast, MHC
class II molecules traffic to late endosomal compart-
ments for sampling internalized exogenously derived
peptides and mediate activation of CD41 helper T cellsSummary
to produce immunoregulatory cytokines and to induce
specific humoral responses (Cresswell, 1994). Thus,The ability to sample relevant intracellular compart-
ments is necessary for effective antigen presentation. MHC class I and class II molecules coordinately orches-
trate immune responses against the peptide antigensTo detect peptide antigens, MHC class I and II mole-
cules differentially sample cytosolic and endosomal of pathogens by surveying distinct intracellular compart-
ments.compartments. CD1 constitutes another lineage of
lipid antigen-presenting molecules. We show that The CD1 family of b2-microglobulin-associated, non-
polymorphic glycoproteins mediate an MHC-indepen-CD1b traffics deeply into late endosomal compart-
ments, while CD1a is excluded from these compart- dent presentation of lipid and glycolipid antigens (Beck-
man et al., 1994; Sieling et al., 1995; Kawano et al.,ments and instead traffics independently in the recy-
cling pathway of the early endocytic system. Further, 1997; Moody et al., 1997; Rosat et al., 1999) as well
as glycosylphosphatidylinositol (GPI)-anchored proteinsCD1b but not CD1a antigen presentation is dependent
upon vesicular acidification. Since lipids and various (Schofield et al., 1999) to a variety of T cells that function
against infection with pathogens. Mycobacteria-infectedbacteria are known to traffic differentially, either pene-
trating deeply into the endocytic system or following cells are detected and killed by group 1 CD1 (CD1a,
CD1b, and CD1c)-restricted T cells that recognize lipidthe route of recycling endosomes, these findings eluci-
date efficient monitoring of distinct components of the and glycolipid antigens derived from phagocytosed in-
tracellular mycobacteria (Stenger et al., 1997), and aendocytic compartment by CD1 lipid antigen-present-
ing molecules. direct pathway for elimination of released microbes has
been proposed through granulysin produced by these
cells (Stenger et al., 1998). Group 2 CD1 (CD1d)-restrictedIntroduction
immune responses have been shown to control humoral
immunity against parasites (Schofield et al., 1999). MostIn order to initiate specific T lymphocyte±mediated im-
of these CD1 isoforms appear to monitor infection withmune responses against viral and microbial infection,
pathogens by sampling antigens in endosomal compart-accurate information of invading pathogens must be
ments. They contain a cytoplasmic tail tyrosine-basedconveyed to the host immune system. Presenting for-
sequence that directs their trafficking to endosomes toeign molecular components of the pathogen or their
which some CD1-restricted lipid antigens are known tofragments to T cells is a pivotal step in initiating the
be delivered (Sugita et al., 1996; Prigozy et al., 1997;adaptive immune response. The immune system has
Brossay et al., 1998; Jackman et al., 1998; Chiu et al.,evolved at least three major types of molecules capable
1999; Rodionov et al., 1999). They also require endoso-of presenting antigens to T cells; two types (class I and
mal acidification in order to present lipid antigens to Tclass II) encoded by the major histocompatibility com-
cells (Porcelli et al., 1992; Kawano et al., 1997).plex (MHC) and one type encoded by the CD1 complex
CD1a molecules are prominently expressed on somelocated outside of the MHC region. These antigen-pre-
types of professional antigen-presenting cells (APCs),senting molecules present peptide and lipid antigens,
such as epidermal Langerhans cells (Caux et al., 1992),respectively, and thus appear to mediate distinct but
bronchial dendritic cells (Tazi et al., 1993), and mono-complementary pathways of host defense against infec-
cyte-derived dendritic cells (Porcelli et al., 1992). CD1a-tion (Germain and Margulies, 1993; Porcelli and Modlin,
restricted T cells express T cell receptor (TCR) a and b1999).
chains and CD8 a and b chains and recognize and kill
microbe infected dendritic cells (Stenger et al., 1998;§ To whom correspondence should be addressed (e-mail: mbrenner@
rics.bwh.harvard.edu). Rosat et al., 1999). However, CD1a is unique compared
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to all the other CD1 isoforms, as it lacks the tyrosine-
based cytoplasmic tail motif (Calabi and Milstein, 1986)
that has been demonstrated to mediate endosomal lo-
calization of other CD1 isoforms (Sugita et al., 1996;
Prigozy et al., 1997; Brossay et al., 1998; Jackman et
al., 1998; Chiu et al., 1999; Rodionov et al., 1999). Thus,
we hypothesized that CD1a might survey distinct intra-
cellular compartments and mediate an antigen presen-
tation pathway fundamentally separate from that medi-
ated by the other CD1 and MHC molecules.
In the present study, we demonstrate that unlike
CD1b, which requires endosomal acidification for its
efficient binding and presentation of mycobacterial lipid
antigens, CD1a-mediated antigen presentation was in-
dependent of endosomal acidification. Consistent with
this functional difference, immunofluorescence micro-
scopic studies as well as electron microscopic analysis
revealed anatomical separation of intracellular CD1a
and CD1b molecules. Whereas CD1b was found in late
endosomal and lysosomal vesicles that expressed lyso- Figure 1. Intracellular Localization of CD1a Was Distinct from that
some-associated membrane protein-1 (LAMP-1), CD1a- of the Other CD1 Isoforms
containing intracellular vesicles were completely nega- HeLa cell transfectants expressing either CD1a (A), CD1b (B), CD1c
tive for this lysosomal marker protein. Furthermore, (C), or CD1d (D) were fixed with 2% formaldehyde and permeabilized
with 0.2% saponin. The cells were then labeled with mouse mono-these CD1a-containing vesicles were identified as part
clonal antibodies to the relevant CD1 isoforms followed by incuba-of the recycling vesicle compartment of the early endo-
tion with fluorescein isothiocyanate (FITC)-conjugated donkey anti-cytic system, since accumulation of the T27N mutant
body to mouse IgG. Magnification, 6003.
of ARF6, a small GTPase that regulates transport of
recycling vesicles to the cell surface (Peters et al., 1995a;
D'Souza-Schorey et al., 1998), was observed in CD1a- 1996). CD1c and CD1d were also found in peripherally
containing but not CD1b-containing vesicles. We pro- distributed vesicles (Figures 1C and 1D, respectively),
pose that these differences between CD1a and CD1b albeit less prominently than CD1b. In contrast, promi-
allow the CD1 system to efficiently monitor phagocy- nent plasma membrane staining was observed for CD1a,
tosed mycobacteria by surveying distinct subcompart- and the peripherally distributed vesicles seen for the
ments of the endocytic system. other CD1 molecules were not apparent (Figure 1A). To
further detect intracellular staining, either CD1a-trans-
fected or CD1b-transfected HeLa cells were double-Results
labeled with antibodies to the relevant CD1 isoforms
and LAMP-1, a marker of late endosomes and lyso-Difference in Steady State Intracellular Localization
between CD1a and the Other CD1 Isoforms somes, and viewed by confocal microscopy (Figure 2).
CD1b was found in numerous intracellular vesiclesWe and others showed previously that a tyrosine-based
endosomal targeting sequence (YXXZ, where Y is tyro- (green vesicles in Figure 2D), and a nearly identical
vesicular distribution was observed for endogenoussine, X is any amino acid, and Z is a hydrophobic amino
acid) that is present in the short cytoplasmic domain of LAMP-1 expression (red vesicles in Figure 2E). The
CD1b- and LAMP-1-containing vesicles were almost en-most CD1 proteins is crucial for their localization to
endosomes and for their presentation of endocytosed tirely superimposable (yellow vesicles in Figure 2F), con-
firming the prominent localization of CD1b in late endo-lipid antigens (Sugita et al., 1996; Brossay et al., 1998;
Jackman et al., 1998; Chiu et al., 1999). CD1a is the somal and lysosomal compartments. In contrast, there
was virtually no colocalization of CD1a and LAMP-1only member of the human CD1 family that lacks this
endosomal targeting motif (Calabi and Milstein, 1986; (Figure 2C). Instead, a cluster of CD1a-positive, LAMP-
1-negative intracellular vesicles was noted prominentlyBalk et al., 1989), and yet mycobacterial lipid antigen-
specific, CD1a-restricted T cells as well as CD1b- and in a juxtanuclear position (Figure 2A, shown with arrow-
heads). This striking difference in intracellular steadyCD1c-restricted T cells can reconize and kill mycobac-
teria-infected dendritic cells (Stenger et al., 1997, 1998; state localization between CD1a and CD1b suggested
that these molecules might mediate distinct pathwaysRosat et al., 1999), implying that CD1a may encounter
and bind antigens derived from endosome-resident my- for antigen presentation.
cobacteria in a site distinct from that for the other CD1
isoforms. Immunofluorescence microscopic analysis of Differential Effect of Blockers of Endosomal
Acidification on CD1a- and CD1b-MediatedHeLa cell transfectants expressing each of the CD1 iso-
forms revealed a striking difference in the localization Antigen Presentation
CD1b-restricted exogenous glycolipid antigens, such asof CD1a compared with the other CD1 molecules (Figure
1). CD1b prominently localized in peripherally distrib- lipoarabinomannan, are taken up by APCs and delivered
to LAMP-11 late endosomal compartments, where theyuted vesicles (Figure 1B) that we previously showed
belonged to the late endocytic system (Sugita et al., colocalize with CD1b (Prigozy et al., 1997). Thus, one
Pathways for Antigen Presentation by CD1a and CD1b
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Figure 2. CD1a Was Almost Excluded from LAMP-11 Late Endosomes and Lysosomes
HeLa cell transfectants expressing either CD1a (upper panels) or CD1b (lower panels) were fixed and permeabilized. The cells were then
double-labeled with mouse monoclonal antibodies to the relevant CD1 isoforms (detected with FITC-conjugated donkey anti-mouse IgG
[green]) and a rabbit antiserum against human LAMP-1 (detected with Texas red±conjugated donkey anti-rabbit IgG [red]) and analyzed by
cofocal microscopy. Fluorescent confocal images of CD1a1 (upper panels) and CD1b1 (lower panels) HeLa cells were obtained for CD1
expression (green, [A] and [D]) and endogenous LAMP-1 (red, [B] and [E]). The two images were then superimposed to detect any cellular
compartments expressing both CD1 and LAMP-1 (yellow, [C] and [F]). Scale bars, 5 mm.
can hypothesize that CD1b encounters and binds lipid requirement for endosomal acidification (Figure 3B,
right). In contrast, little if any effect of this drug wasantigens in these acidic endosomal compartments.
Consistent with this hypothesis, binding of lipid antigens detected, under identical conditions, on the CD1a-medi-
ated antigen presentation to CD8-2/J.RT3 cells (Figureto CD1b requires an acidic environment both in vitro
and in vivo (Porcelli et al., 1992; Ernst et al., 1998). Since 3B, left).
Given that these distinctive features of CD1a wereCD1a appears to be virtually excluded from these CD1b1
highly acidic late endosomes and lysosomes (Figure 2), more comparable to those of MHC class I than class II,
we initially hypothesized that CD1a, like MHC class I,we reasoned that CD1a-mediated antigen presentation
might not require endosomal acidification. Thus, we might bind antigens in the ER. However, this did not
appear to be the case, since CD1a-restricted recogni-compared the effect of concanamycin B, which specifi-
cally inhibits the vacuolar proton ATPase in endocytic tion of lipid antigen by CD8-2/J.RT3 was not affected
by treatment of APCs with brefeldin A (Figure 3C, right).compartments (Benaroch et al., 1995; Sugita and Bren-
ner, 1995), on antigen presentation mediated by CD1a The complete blocking effect of this drug on protein
transport from pre-Golgi to post-Golgi compartmentsand CD1b. In order to detect antigen presentation by
these CD1 isoforms, we used TCR-deficient Jurkat cells was confirmed by total blockade of lysozyme secretion
(Figure 3C, left). Radiolabeled lysozyme was retained(J.RT3) reconstituted with the specific TCR a and b
chains derived from two mycobacterial lipid antigen- intracellularly in the presence of brefeldin A, whereas it
was secreted into the medium in the absence of thespecific T cell lines. CD8-2/J.RT3 was obtained by trans-
fection of J.RT3 cells with the TCR a and b chain cDNAs drug. These results suggested that CD1a antigen load-
ing would occur in a post-Golgi compartment. To exam-isolated from the CD8-2 CD1a-restricted T cell line,
whereas LDN5/J.RT3 was obtained by transfection with ine the possibility that endocytosis might be required
for CD1a antigen presentation in this in vitro model,the TCR a and b chain cDNAs isolated from the LDN5
CD1b-restricted T cell line (Grant et al., 1999). In both APCs that were fixed with glutaraldehyde to block endo-
cytosis were tested for their ability to present lipid anti-cases, reconstitution with the relevant pair of specific
TCR a and b chains was sufficient to transfer both anti- gen to T cells. Recognition of lipid antigen by LDN5/
J.RT3 occurred when APCs were antigen pulsed andgen specificity and CD1 restriction. Thus, dose-depen-
dent, specific mycobacterial lipid antigen recognition by then fixed, but not when antigen pulsed after fixation,
indicating that uptake of lipid antigen and its intracellularCD8-2/J.RT3 and LDN5/J.RT3 occurred only when JY
transfectant cells expressing the correct CD1 isoform delivery were required for CD1b-mediated antigen pre-
sentation (Figure 3D, lower panel). Similarly, only a mar-were used as APCs (Figure 3A). As expected, the CD1b-
mediated antigen presentation to LDN5/J.RT3 was com- ginal recognition of lipid antigen by CD8-2/J.RT3 was
detected when APCs were fixed and then pulsed withpletely blocked by concanamycin B, emphasizing the
Immunity
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Figure 3. CD1a-Mediated Antigen Presentation Was Resistant to Concanamycin B and Brefeldin A
(A) Untransfected JY cells and JY cells stably transfected with either CD1a (JY/CD1a) or CD1b (JY/CD1b) were incubated overnight with
indicated concentrations of either the semipurified Mycobacterium tuberculosis (M.tb) lipid antigen preparation (for CD8-2/J.RT3) (Rosat et
al., 1999) or purified glucose monomycolate (GMM) (for LDN5/J.RT3) (Moody et al., 1997) and fixed with 0.08% glutaraldehyde. The TCR
transfectant cells were cultured with these fixed APCs, and IL-2 production was measured as described in Experimental Procedures.
(B) JY/CD1a and JY/CD1b were preincubated with 10 nM concanamycin B (Con B) for 30 min and then washed and incubated overnight with
indicated concentrations of specific antigen preparations either in the presence or absence of 10 nM concanamycin B. The cells were then
washed, fixed, and incubated with CD8-2/J.RT3 (left) and LDN5/J.RT3 (right), respectively, and IL-2 release into the media was measured.
(C) HeLa cells transiently transfected with CD1a were preincubated with 10 mg/ml brefeldin A (BFA) for 30 min and then washed and incubated
with indicated concentrations of the semipurified M.tb antigen preparation either in the presence or absence of 10 mg/ml brefeldin A. After
5.5 hr, cells were washed, fixed, and incubated with CD8-2/J.RT3, and IL-2 release was measured (right). To confirm the blocking effect of
brefeldin A, HeLa cells transiently transfected with lysozyme cDNA were metabolically pulse-radiolabeled with [35S]methionine for 5 min and
then chased in regular media for 6 hr either in the presence or absence of 10 mg/ml brefeldin A. After the chase, secreted and intracellularly
retained lysozyme were detected by immunoprecipitation with anti-lysozyme antibody from the supernatant and the cell lysate, respectively.
The immunoprecipitated proteins were analyzed on a 12% SDS-PAGE gel. The position of lysozyme is indicated with an arrow.
(D) Peripheral blood monocytes stimulated with GM-CSF and IL-4 were incubated for 4 hr with specific antigen preparations (0.75 mg/ml of
the semipurified M.tb lipid antigen preparation for CD8-2/J.RT3 or 1 mg/ml of GMM for LDN5/J.RT3) either before or after fixation with 0.1%
glutaraldehyde. The cells were then washed and incubated with CD8-2/J.RT3 (upper panel) or LDN5/J.RT3 (lower panel), and IL-2 release
into the media was measured.
antigen (Figure 3D, upper panel), suggesting that the (Caux et al., 1992). We employed immunogold-labeled
transmission electron microscopy to analyze Langer-cell surface was not the major site for CD1a antigen
binding. In addition, the observation that phagocytosed hans cells for the localization of CD1a expression. CD1a
was expressed abundantly on the plasma membraneintracellular mycobacteria were readily detected by the
CD8-2 T cells (Stenger et al., 1997) led us to the hypothe- (p) of Langerhans cells but not on the plasma membrane
of adjacent keratinocytes (Kc), indicating the specificitysis that CD1a might bind antigen at an intracellular site
that belonged to the post-Golgi compartment. of the labeling (Figure 4). In addition, prominent intracel-
lular CD1a labeling was detected in small vesicular or
tubular structures clustered mainly at a juxtanuclear po-Detection of CD1a1 Vesicles in Professional APCs
To gain further insight into the intracellular trafficking of sition, some of which were identical in shape and in size
to Birbeck granules (Kashihara et al., 1986) (Figure 4,CD1a, we studied untransfected physiological APCs.
Epidermal Langerhans cells are key professional APCs arrows). Although the origin and the function of these
Langerhans cell±specific vesicles is only partially under-involved in skin immunity (Streilein et al., 1990) that ex-
press high levels of CD1a molecules but little CD1b stood, several lines of evidence suggest that Birbeck
Pathways for Antigen Presentation by CD1a and CD1b
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Figure 4. Immunoelectron Micrograph of Thin
Cryosections of Human Epidermal Langer-
hans Cells In Situ
A skin specimen from punch biopsy was ana-
lyzed for CD1a expression. In epidermal
Langerhans cells, CD1a was found in small
intracellular vesicles, including typical Bir-
beck granules (shown with arrows), as well
as on the plasma membrane (p). Abbrevia-
tions: m, mitochondria; n, nucleus. Scale
bars, 200 nm.
granules are formed by invaginations of the plasma 2), few CD1a molecules were detected in endosomal
and lysosomal compartments of these dendritic cellsmembrane and mediate an endocytic function (Hanau
et al., 1987; Ray et al., 1989; Bartosik, 1992). Thus, we (data not shown), including the MHC class II compart-
ment or MIIC (Peters et al., 1991, 1995b) in which MHCspeculated that CD1a might be internalized from the cell
surface and transported intracellularly in Langerhans class II and CD1b are proposed to bind peptide and
lipid antigens, respectively (Sanderson et al., 1994; Tulpcells via Birbeck granules.
In order to examine the possibility of CD1a internaliza- et al., 1994; Sugita et al., 1996; Prigozy et al., 1997).
Interestingly, similar to epidermal Langerhans cells, wetion from the cell surface more directly, we obtained
monocyte-derived CD1a1 dendritic cells in vitro by stim- detected small intracellular vesicles that expressed
CD1a molecules in these monocyte-derived dendriticulating human peripheral blood monocytes with granu-
locyte-macrophage colony±stimulating factor (GM-CSF) cells (Figure 5, shown with arrows). These CD1a1 vesi-
cles lacked an electron-dense coat structure and thusand interleukin-4 (IL-4) (Porcelli et al., 1992). Following
immunogold labeling with an antibody to CD1a, trans- were distinct from clathrin-coated vesicles. Given that
CD1a was internalized in clathrin-coated pits from themission electron microscopy readily detected CD1a in
plasma membrane±associated clathrin-coated pits (Fig- cell surface and that CD1a was not significantly trans-
ported to late endosomes and lysosomes, we reasonedure 5, arrowheads) and vesicles (Figure 5, inset), indicat-
ing that delivery via clathrin-coated pits and vesicles that these CD1a1 vesicles might be recycling vesicles
delivering internalized proteins back to the cell surfacewas likely a prominent pathway for CD1a internaliza-
tion. Consistent with the lack of CD1a expression in instead of transporting them more deeply into the endo-
cytic system.LAMP-11 endocytic compartments in HeLa cells (Figure
Expression of CD1a but not CD1b
in Recycling Vesicles
Recycling vesicles that contain recycling proteins accu-
mulate at a juxtanuclear position before trafficking to the
cell surface and are collectively referred to as recycling
endosomes (Daro et al., 1996). A specific marker for
these recycling vesicles has not been established. How-
ever, we and others previously demonstrated that a
small GTPase, ARF6, regulates transport of recycling
vesicles from recycling endosomes to the cell surface
and that overexpression of the T27N mutant of ARF6
(ARF6-T27N) perturbs the GTPase cycle, which results
in its accumulation in recycling vesicles (D'Souza-
Schorey et al., 1995, 1998; Peters et al., 1995a). Thus,
we tested whether CD1a1 intracellular vesicles could
be labeled with ARF6-T27N. HeLa cells stably trans-
Figure 5. Immunoelectron Micrographs of Thin Cryosections of In fected with either CD1a or CD1b were transiently super-
Vitro±Derived Dendritic Cells transfected with ARF6-T27N, double-labeled with anti-
Peripheral blood monocytes stimulated with GM-CDF and IL-4 were bodies to the relevant CD1 isoforms and ARF6, and
analyzed for CD1a expression. CD1a was found in plasma mem- analyzed by confocal microscopy. ARF6-T27N was de-
brane±associated clathrin-coated pits (shown with arrowheads)
tected in a cluster of vesicles at a juxtanuclear positionand clathrin-coated vesicles (inset, shown with an arrowhead) as
as well as in some peripherally distributed vesicles (Fig-well as in small noncoat vesicles (shown with arrows). Scale bars,
200 nm. ures 6B and 6E). A similar vesicular distribution was
Immunity
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Figure 6. CD1a-Containing Intracellular Vesicles but Not CD1b-Containing Vesicles Were Labeled with ARF6/T27N
HeLa cell transfectants expressing either CD1a (upper panels) or CD1b (lower panels) were grown on coverslips and transiently supertransfected
with ARF6/T27N cDNA. The cells were then fixed and permeabilized, and double-labeling with mouse antibodies to either CD1a or CD1b
(detected with FITC-conjugated donkey anti-mouse IgG [green]) and rabbit anti-ARF6 antibody (detected with Texas red±conjugated donkey
anti-rabbit IgG [red]) was performed. Fluorescent confocal images were obtained for CD1a (green, [A]), CD1b (green, [D]) and ARF6 (red, [B]
and [E]) expression. The corresponding two images were then superimposed to detect vesicles expressing both CD1 and ARF6 (yellow, [C]
and [F]). Scale bars, 5 mm.
detected for CD1a, and the CD1a- and the ARF6-T27N- can eliminate the infected cells (Brunt et al., 1990;
Bouwer et al., 1992; Mazzaccaro et al., 1998), althoughcontaining intracellular vesicles were almost entirely su-
perimposable (Figure 6C). In contrast, the distribution this pathway has often proved difficult to detect for
many intracellular bacteria (Kaufmann, 1993). Here, weof CD1b-containing intracellular vesicles (Figure 6D) dif-
fered significantly from that of ARF6-T27N-containing show that CD1a molecules avoid entry into late endoso-
mal and lysosomal compartments and do not requirevesicles (Figure 6E), demonstrated by the presence of
numerous separate green and red vesicles after super- endosomal acidification or delivery of antigens to the
ER for their antigen presentation, predicting the abilityimposition of the two images (Figure 6F). Thus, endoso-
mal trafficking pathways for CD1a and CD1b were to offer the immune system an alternate opportunity to
recognize phagocytosed microbes separate from theclearly separated, based on their colocalization with ei-
ther ARF6-T27N or LAMP-1. Whereas CD1b, like MHC other CD1 isoforms and MHC class I and class II mole-
cules.class II, trafficked deeply into the LAMP-11 late endo-
cytic system, CD1a followed a recycling pathway of the Mycobacteria reside in endosomes by preventing
phagosome-lysosome fusion (Gordon et al., 1980; Hartearly endocytic system via ARF6-regulated recycling
vesicles. and Young, 1991). However, lipids and glycolipids de-
rived from endosome-resident mycobacteria can escape
from phagosomes and distribute to other subcellularDiscussion
compartments (Xu et al., 1994). Interestingly, Mukherjee
et al. (1999) recently showed that a pathway for endoso-Here, we functionally and anatomically separate the an-
tigen presentation pathways mediated by CD1a and mal trafficking of lipids is controlled by the basic struc-
ture of their hydrophobic acyl chains. Whereas lipidsCD1b molecules. The CD1b pathway resembles that
of MHC class II in localization to late endosomal and with saturated long (and thus rigid) acyl chains are
sorted at the sorting endosomes toward lysosomes,lysosomal compartments and in the requirement for en-
dosomal acidification in order to function. However, those with unsaturated short (and thus more mobile)
acyl chains are preferentially transported to recyclingblockade of endosomal acidification as well as preven-
tion of phagosome-lysosome fusion are well-known in- endosomes. Indeed, CD1b-restricted antigens so far
identified are lipids and glycolipids with extremely longvasion mechanisms employed by phagocytosed mi-
crobes, which may abrogate both CD1b- and MHC class acyl chains (Beckman et al., 1994; Sieling et al., 1995;
Moody et al., 1997). In addition, shortening the acyl chainII±mediated pathways (Kaufmann, 1993; Sturgill-Kos-
zycki et al., 1994). For peptide antigens, access to the and the sphingosine base of a-galactosylceramide,
which is presented by CD1d in an endosomal acidifica-cytosol by escape from endosomes and their subse-
quent delivery to the ER enables the effective elicitation tion±dependent manner like CD1b-restricted antigens,
diminishes specific T cell responses (Kawano et al.,of MHC class I±restricted, CD81 cytotoxic T cells that
Pathways for Antigen Presentation by CD1a and CD1b
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Moreover, the maneuvering of bacteria to prevent their
trafficking into acidified, deep endocytic compartments
points to the importance of sampling both early and
late pathways of endocytic trafficking. The ability of the
immune system to present the universe of foreign lipid,
glycolipid, and lipoprotein antigens of microbes offers
an important opportunity to detect and eliminate patho-
gens. The differential trafficking of the CD1 isoforms
allows these antigen-presenting molecules to broadly
sample vesicular compartments and detect microbes
that constantly attempt to evolve evasive mechanisms.
It seems likely that MHC and CD1 antigen-presenting
molecules offer complementary opportunities that func-
tion in host defense.
Experimental Procedures
Cell Lines and Antibodies
Figure 7. Intracellular Trafficking of CD1 Molecules and Mycobac- The J.RT3 cells reconstituted with the mycobacterial lipid antigen±
teria-Derived Lipid Antigens in Mycobacteria-Infected Cells specific, CD1-restricted TCRs (CD8-2/J.RT3 and LDN5/J.RT3) have
been described (Grant et al., 1999). These TCR-reconstituted cells
were cultured in RPMI 1640 (GIBCO±BRL) complete medium (10%
heat-inactivated fetal calf serum, 20 mM HEPES, 2 mM L-glutamine,1997; Brossay et al., 1998). Although the structural basis
1 mM sodium pyruvate, and 55 mM 2-mercaptoethanol [all fromfor lipid antigens presented by CD1a is not fully charac-
GIBCO±BRL]), containing G418 (GIBCO±BRL) (1 mg/ml) and hygro-terized, it seems likely that certain lipid antigens derived
mycin B (GIBCO±BRL) (500 mg/ml). A human B lymphoblastoid cell
from phagocytosed mycobacteria are delivered, based line, JY (Russell et al., 1996), was transfected with either CD1a cDNA
on the chemical nature of their hydrophobic portion, in p3-9 or CD1b cDNA in p3-9 (Sugita et al., 1996) by electroporation
and cultured in RPMI 1640 complete medium containing hygromycinto either recycling endosomes or late endosomes and
B (200 mg/ml). The high-expressing cells were collected by fluores-lysosomes and sampled by CD1a or CD1b molecules,
cence-activated cell sorting and used as APCs. IL-2-depenent HT-2respectively (Figure 7). These features of distinct intra-
cells (Grant et al., 1999) were cultured in RPMI complete mediumcellular trafficking and intracellular requirements for lipid
supplemented with 1 nM recombinant human IL-2 (Ajinomoto, Ka-
antigen presentation by CD1a and CD1b enable the im- wasaki, Japan). HeLa cell transfectants expressing CD1 molecules
mune system to efficiently monitor intracellularpathogens. (Sugita et al., 1997; Spada et al., 1998) were grown in Dulbecco's
modified essential medium supplemented with 10% fetal calf serumCD1a molecules are prominently expressed on acti-
and 2 mM L-glutamine. The mouse monoclonal antibodies 10H3vated monocyte-derived dendritic cells as well as epi-
(anti-CD1a) (Olive et al., 1984), 4A7.6 (anti-CD1b) (Olive et al., 1984),dermal Langerhans cells and dendritic cells in epithelia
F10/21A3.1 (anti-CD1c) (Grant et al., 1999), CD1d51 (anti-CD1d) (Ex-of certain tissues, such as the bronchus (Tazi et al.,
ley et al., 1997; Spada et al., 1998), and F10.6.6 (anti-lysozyme) (Aoe
1993), the gingiva (Crawford et al., 1989), the conjunctiva et al., 1997) as well as rabbit polyclonal antisera against LAMP-1
(Yoshida et al., 1997), the vagina, and the cervix (Miller (Carlsson et al., 1988) and ARF6 (D'Souza-Schorey et al., 1998) have
been described.et al., 1992). This distribution suggests that CD1a may
play a role in antigen presentation at sites constantly
T Cell Transfectants Stimulation Assayexposed to external pathogens. CD1a and CD1b are not
Untransfected JY cells and JY cells stably transfected with eithernecessarily expressed in a coordinate fashion. Probably
CD1a (JY/CD1a) or CD1b (JY/CD1b) were incubated overnight withthe best characterized difference in expression of these
indicated concentrations of either the semipurified Mycobacterium
two molecules is seen on epidermal Langerhans cells. tuberculosis lipid antigen preparation (for CD8-2/J.RT3) (Rosat et
Freshly isolated Langerhans as well as cytokine-induced al., 1999) or purified glucose monomycolate (GMM) (for LDN5/J.RT3)
(Moody et al., 1997), washed and fixed with 0.08% glutaraldehyde.Langerhans cells express high levels of CD1a with virtu-
The TCR transfectant cells (5 3 104/well) were cultured with theseally no CD1b on the cell surface (Caux et al., 1992). We
fixed APCs in the presence of 10 ng/ml phorbol myristate acetateexamined epidermal Langerhans cells in situ for their
(PMA) using 96-well, flat-bottomed microtiter plates (200 ml media/intracellular and surface expression of CD1b by immu-
well). Aliquots of the culture supernatants were collected after 24
nogold-labeled electron microscopy, but no CD1b ex- hr, and the amount of interleukin-2 (IL-2) released into the superna-
pression was detected in these cells (data not shown). tants was measured as described (Grant et al., 1999) using the HT-2
indicator cells, whose proliferation is dependent on IL-2.Thus, CD1a may play a dominant role compared to other
To examine the effect of concanamycin B, JY/CD1a and JY/CD1bCD1 isoforms on certain cells or in particular locations
were preincubated with 10 nM concanamycin B (gift of Dr. Hiddebased on its differential cellular expression.
Ploegh) for 30 min and then washed and incubated overnight withThe ability to sample cytosolic and endosomal com-
indicated concentrations of specific antigen preparations either in
partments by MHC class I and class II molecules, re- the presence or absence of 10 nM concanamycin B. Subsequently,
spectively, is essential for the generation of effective the JY/CD1a and JY/CD1b cells were washed, fixed, and incubated
with CD8-2/J.RT3 and LDN5/J.RT3, respectively, and IL-2 produc-host responses to peptide antigens. Here we show that
tion by the T cells was measured as described above. To examinelipid antigen-presenting CD1 isoforms traffic in distinct
the effect of brefeldin A, HeLa cells were transfected with CD1acomponents of the endocytic system in a manner that
cDNA in pSRaneo (Porcelli et al., 1992) by a standard calcium phos-predicts comprehensive antigen sampling. The differen-
phate precipitation method (Chen and Okayama, 1988). Two days
tial trafficking of exogenous lipids into the recycling after transfection, cells were preincubated with 10 mg/ml brefeldin A
pathway or the deep endocytic pathway correlates with (Epicentre Technologies) for 30 min and then washed and incubated
with indicated concentrations of the semipurified M. tuberculosisthe differential trafficking of CD1a and CD1b molecules.
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antigen preparation either in the presence or absence of 10 mg/ml help with confocal microscopy. This work was supported by grants
from the National Institutes of Health.brefeldin A. After 5.5 hr, cells were washed, fixed, and incubated
with CD8-2/J.RT3, and IL-2 release was measured, using HT-2 cells
as described above.
Received September 1, 1999; revised November 8, 1999.
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